CEACAM5 and medullary thyroid gland carcinoma: However, it is extremely important to establish an appropriate stratification of the clinical risk of the patient to whom these drugs will be administered, since a significant number of patients with MTC and residual or recurrent disease have an indolent course characterized by stable or slowly increasing Ct and/or CEA levels.